Most Recent
The Commonwealth of Australia has called for the appointment of an amicus to scrutinise the $212.5 million settlement reached in several class action against it over allegedly toxic firefighting foam used on government military bases.
The Federal Government will pay $212.5 million to settle three class actions over the use of allegedly toxic firefighting foam at government military bases.
The Federal Court judge overseeing three class actions against the Commonwealth of Australia over allegedly toxic firefighting foam has questioned the terms of the in-principle settlement reached last week, including whether the settlement amount should remain confidential.
Three Sydney commercial landlords whose properties were compulsorily acquired to make way for the WestConnex project have come to the end of the road in their fight for $56.5 million in compensation, with the High Court refusing to hear their case.
A group of Sydney commercial landlords whose properties were compulsorily acquired for the WestConnex project have lost an appeal seeking $56.5 million in compensation, after the Valuer-General offered them just over half that amount.
Two companies owned by the ex-director of Dial A Dump have failed in a bid to secure $584 million in compensation for land compulsorily acquired by the NSW Government for the WestConnex project, with the court granting them less than 10 per cent of that amount.
A court has barred US drug company Merck Sharp & Dohme from denying that an agreement made with German pharmaceutical company Merck KGaA was governed by German law, settling a key question before a trade mark case between the two drug giants goes to trial.
Boutique class actions law firm Phi Finney McDonald has won its bid to reserve costs incurred before its case was permanently stayed in the AMP shareholder class action beauty contest, after the firm racked up at least 1,345 hours in “sunk costs”.
The Copyright Tribunal erred by including rights in a reissued Foxtel licence agreement that fell outside the authority of the licence grant holder, the Phonographic Performance Company of Australia, the Full Federal Court has found.
In its opening submissions in a trade mark case brought by Botox maker Allergan, Australian cosmetics brand Self Care compared its used of the word Botox to describe its alternative cosmetic products to the iPhone secondary accessories market, saying its use did not imply an affiliation with the injectable wrinkle treatment's maker.